Literature DB >> 9129947

Lipid and lipoprotein modification by advanced glycosylation end-products: role in atherosclerosis.

R Bucala1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1997        PMID： 9129947     DOI： 10.1113/expphysiol.1997.sp004028

Source DB:  PubMed          Journal:  Exp Physiol        ISSN： 0958-0670            Impact factor:   2.969


× No keyword cloud information.
  9 in total

1.  Nonobese diabetic mice have diminished gallbladder motility and shortened crystal observation time.

Authors:  Shannon J Graewin; James M Kiely; Keun-Ho Lee; Carol L Svatek; Attila Nakeeb; Henry A Pitt
Journal:  J Gastrointest Surg       Date:  2004-11       Impact factor: 3.452

Review 2.  Advanced glycation end products and vascular structure and function.

Authors:  Georgia Soldatos; Mark Emmanuel Cooper
Journal:  Curr Hypertens Rep       Date:  2006-12       Impact factor: 5.369

3.  Insulin resistance causes human gallbladder dysmotility.

Authors:  Attila Nakeeb; Anthony G Comuzzie; Hayder Al-Azzawi; Gabriele E Sonnenberg; Ahmed H Kissebah; Henry A Pitt
Journal:  J Gastrointest Surg       Date:  2006 Jul-Aug       Impact factor: 3.452

4.  The expression of apolipoprotein B epitopes is normal in LDL of diabetic and end-stage renal disease patients.

Authors:  S Braschi; M Geoffrion; A Nguyen; Y Gaudreau; R W Milne
Journal:  Diabetologia       Date:  2006-04-04       Impact factor: 10.122

5.  Aminoguanidine prevents age-related aortic stiffening in Fisher 344 rats: aortic impedance analysis.

Authors:  Kuo-Chu Chang; Kwan-Lih Hsu; Ying-I Peng; Fong-Chu Lee; Yung-Zu Tseng
Journal:  Br J Pharmacol       Date:  2003-07-29       Impact factor: 8.739

6.  Aminoguanidine prevents arterial stiffening and cardiac hypertrophy in streptozotocin-induced diabetes in rats.

Authors:  Kuo-Chu Chang; Kwan-Lih Hsu; Chuen-Den Tseng; Yue-Der Lin; Yi-Li Cho; Yung-Zu Tseng
Journal:  Br J Pharmacol       Date:  2006-04       Impact factor: 8.739

7.  Aminoguanidine prevents the impairment of cardiac pumping mechanics in rats with streptozotocin and nicotinamide-induced type 2 diabetes.

Authors:  M-S Wu; J-T Liang; Y-D Lin; E-T Wu; Y-Z Tseng; K-C Chang
Journal:  Br J Pharmacol       Date:  2008-03-31       Impact factor: 8.739

8.  Prevention of arterial stiffening by pyridoxamine in diabetes is associated with inhibition of the pathogenic glycation on aortic collagen.

Authors:  Kuo-Chu Chang; Jin-Tung Liang; Pei-Shan Tsai; Ming-Shiou Wu; Kwan-Lih Hsu
Journal:  Br J Pharmacol       Date:  2009-08       Impact factor: 8.739

9.  Synthesis, Purification, and Mass Spectrometric Characterization of Stable Isotope-Labeled Amadori-Glycated Phospholipids.

Authors:  Xiaobo He; Qibin Zhang
Journal:  ACS Omega       Date:  2018-11-19
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.